Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid

EU orphan designation number: EU/3/10/761   
Active ingredient: 3-(6-(1-(2,2-difluorobenzo [d] [1,3] dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl)benzoic acid
Indication: Treatment of cystic fibrosis
Sponsor: Vertex Pharmaceuticals (U.K.) Limited
Cardinal Point, Park Road, Rickmansworth, Herts WD3 1RE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/08/2010 Centralised Orphan - Designation EMA/OD/024/10 (2010)5528 of 04/08/2010
22/11/2012 Centralised Orphan - Transfer of orphan designation EMA/OD/024/10/T/01 (2012)8590 of 19/11/2012